Article
Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy.
Liver international : official journal of the International Association for the Study of the Liver - 1 Feb 2004
Lin Chih-Lin, Liao Li-Ying, Wang Chaur-Shine, Chen Pei-Jer, Lai Ming-Yang, Chen Ding-Shinn, Kao Jia-Horng
Abstract excerpt
AIM: Lamivudine is effective in hepatitis B e antigen (HBeAg)-positive chronic hepatitis B, but the relapse rate after cessation of treatment is high. The evolution of viral genome may contribute to the viral replication under antiviral pressure of lamivudine. We therefore determined the evolution of hepatitis B virus (HBV) precore/basal core promoter and polymerase genes in HBeAg-positive chronic hepatitis B...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
